Attached files

file filename
8-K - FORM 8-K - NYSE Euronextd390425d8k.htm

Exhibit 99.1

 

LOGO

 

CONTACT - Media:      CONTACT - Investor Relations:    nyx.com
Amsterdam      +31.20.550.4488   

Brussels

   +32.2.509.1392    New York        +1.212.656.5700    Please follow us at:
Lisbon      +351.217.900.029   

London

   +44.20.7379.2789          Exchanges Blog
New York      +1.212.656.2411   

Paris

   +33.1.49.27.11.33          Facebook
                    LinkedIn
                    Twitter

NYSE Euronext Announces Second Quarter 2012 Financial Results

— Second Quarter GAAP Diluted EPS of $0.49 vs. $0.59 in Prior Year —

— Non-GAAP Diluted EPS of $0.51 Excluding Merger Expenses and Exit Costs, Disp. Activities and Discrete Tax Items —

— On Track to Establish NYSE Clearing in June 2013 —

— NYSE Liffe U.S. Launches Futures on the DTCC GCF Repo Index™ —

— Over 110 IPOs in Listings Pipeline —

Financial and Operating Highlights1, 2

 

Diluted EPS of $0.51, down from $0.61

 

Net revenue of $602 million, down 9%, including $22 million negative FX impact

 

Fixed operating expenses of $396 million, down 5% on a constant dollar / portfolio basis

 

Operating income of $206 million, down 15%, including $11 million negative FX impact

 

EBITDA margin of 45% vs. 47%; Debt to EBITDA ratio 2.1times

 

Repurchased 6.9 million shares at average price of $25.60; 11.2 million shares year-to-date

 

Board declares third quarter 2012 cash dividend of $0.30 per share

1

All comparisons versus 2Q11 unless otherwise stated. Excludes merger expenses, exit costs, disposal activities and discrete tax items.

2 

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.

NEW YORK – August 3, 2012 – NYSE Euronext (NYX) today reported net income of $125 million, or $0.49 per diluted share, for the second quarter of 2012, compared to net income of $154 million, or $0.59 per diluted share, for the second quarter of 2011. Results for the second quarter of 2012 and 2011 include $12 million and $18 million, respectively, of pre-tax merger expenses and exit costs. Second quarter 2012 results also include a net $2 million loss from disposal activities related to the previously announced wind down of NYSE Blue. Excluding merger expenses, exit costs, disposal activities and discrete tax items, net income in the second quarter of 2012 was $128 million, or $0.51 per diluted share, compared to $160 million, or $0.61 per diluted share, in the second quarter of 2011.

“We made good progress in executing against our strategy to unlock the inherent value of our community,” said Duncan L. Niederauer, CEO, NYSE Euronext. “We have realigned our client facing and product teams to create a generalist sales force that brings to bear our full-suite of solutions for our clients. We have given notice that we will fully insource clearing and launch NYSE Clearing in June 2013, which will provide us with cost savings and ultimately provide new revenue and better position the Company for the OTC opportunity. Lastly, we made significant headway with our NYSE Liffe U.S. platform with the launch of our GCF repo futures product which fills the increasing market need for a reliable and transparent benchmark for bank funding costs.”


The table below summarizes the financial results1 for the second quarter of 2012:

                              D 2Q12    Year-to-Date      D YTD ‘12
($ in millions, except EPS)    2Q12      1Q12      2Q11      vs. 2Q11    2012      2011      vs. YTD ‘11

Total Revenues2

           $986               $952          $1,092       (10%)          $1,938             $2,240       (13%)
    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

      

Total Revenues, Less Transaction-Based Expenses3

     602         601         661       (9%)      1,203         1,340       (10%)

Other Operating Expenses4

     396         405         419       (5%)      801         834       (4%)
    

 

 

    

 

 

    

 

 

       

 

 

    

 

 

      

Operating Income4

     $206         $196         $242       (15%)      $402         $506       (21%)

Net Income4

     $128         $121         $160       (20%)      $249         $337       (26%)

Diluted Earnings Per Share4

     $0.51         $0.47         $0.61       (16%)      $0.97         $1.28       (24%)

   Operating Margin

     34%         33%         37%       (3 ppts)      33%         38%       (5 ppts)

   Adjusted EBITDA Margin

     45%         44%         47%       (2 ppts)      44%         48%       (4 ppts)

 

1 

A full reconciliation of our non-GAAP results to our GAAP results is included in the attached tables. See also our statement on non-GAAP financial measures at the end of this earnings release.

2 

Includes activity assessment fees.

3 

Transaction-based expenses include Section 31 fees, liquidity payments and routing & clearing fees.

4 

Excludes merger expenses, exit costs, disposal activities and discrete tax items.

“We are making excellent progress on the efficiency and capital deployment streams of Project 14,” commented Michael S. Geltzeiler, Group Executive Vice President and CFO, NYSE Euronext. “Year-to-date, excluding investments and foreign exchange fluctuations, we have reduced operating costs by $35 million, or 4% which puts us on track to exceed our year-one cost savings commitments. On the capital front, we spent $304 million of the $552 million share repurchase authorization, purchasing 11 million shares year-to-date. Ongoing strategic initiatives, combined with our cost reduction plan and lower share count from stock repurchases, should position the Company for a return to earnings growth in 2013 and beyond.”

SECOND QUARTER 2012 CONSOLIDATED RESULTS

Total revenues, less transaction-based expenses, which include Section 31 fees, liquidity payments and routing and clearing fees (net revenue), were $602 million in the second quarter of 2012, down $59 million, or 9% compared to the second quarter of 2011 and included a $22 million negative impact from foreign currency fluctuations. The $37 million decrease in net revenue, on a constant currency basis, compared to the second quarter of 2011 was primarily driven by lower average daily volumes (“ADV”), mostly attributable to the derivatives business.

Other operating expenses, excluding merger expenses and exit costs, were $396 million in the second quarter of 2012, down $23 million, or 5% compared to the second quarter of 2011. Excluding the impact of new business initiatives and an $11 million positive impact attributable to foreign currency fluctuations, other operating expenses were also down $23 million, or 5%, compared to the second quarter of 2011.

Operating income, excluding merger expenses and exit costs, was $206 million, down $36 million, or 15% compared to the second quarter of 2011 and included an $11 million negative impact attributable to foreign currency fluctuations.

Adjusted EBITDA, excluding merger expenses and exit costs was $272 million, down $40 million, or 13% compared to the second quarter of 2011. Adjusted EBITDA margin was 45% in the second quarter of 2012, compared to 47% in the second quarter of 2011.

Non-operating results for the second quarter of 2012 and 2011 includes the impact of New York Portfolio Clearing (loss from associates), NYSE Liffe U.S. (net loss attributable to non-controlling interest) and NYSE Amex Options (net profit attributable to non-controlling interest). The loss attributable to the non-controlling interest related to NYSE Liffe U.S. was $2 million in the second quarter of 2012, based on the partners’ 42% stake in the business. At the end of the second quarter of 2012, NYSE Liffe U.S. sold a 7% equity stake in the business to the existing partner group, raising the partner groups’ collective stake in the business to 49%. The profit attributable to the non-controlling interest related to NYSE Amex Options was $8 million in the second quarter of 2012, based on the partners’ 47.8% stake in the business.

 

2


The effective tax rate for the second quarter of 2012, excluding merger expenses, exit costs and discrete tax items, was approximately 25% compared to approximately 26% for the second quarter of 2011.

The weighted average diluted shares outstanding in the second quarter of 2012 was 253 million, down from 263 million in second quarter of 2011. During the second quarter of 2012, a total of 6.9 million shares were repurchased at an average price of $25.60 per share. The current $552 million stock repurchase authorization has $248 million remaining as of June 30, 2012.

At June 30, 2012, total debt was $2.3 billion. Cash, cash equivalents and short term financial investments (including $153 million related to Section 31 fees collected from market participants and due to the SEC) were $0.4 billion and net debt was $1.9 billion at the end of the second quarter of 2012. The ratio of debt-to-EBITDA at the end of the second quarter of 2012 was 2.1X.

NYSE Euronext entered into a $1 billion senior unsecured credit facility agreement with a three-year maturity. The financing replaces NYSE Euronext’s existing $1.2 billion credit facility, which was entered into in 2007 and was scheduled to mature on July 31, 2012. The new revolving bank facility is available for general corporate purposes and will mature on June 15, 2015.

Total capital expenditures were $41 million in the second quarter of 2012 and $84 million year-to-date. This is in-line with our full-year 2012 capital expenditures guidance.

Headcount as of June 30, 2012 of 3,062 was 17 below first quarter 2012 levels despite the addition of 99 employees from the acquisition of Corpedia in June of 2012. The reduction was due to the wind down of NYSE Blue (66 headcount) and the ongoing staff rationalization program.

The Board of Directors declared a cash dividend of $0.30 per share for the third quarter of 2012. The third quarter 2012 dividend is payable on September 28, 2012 to shareholders of record as of the close of business on September 14, 2012. The anticipated ex-date will be September 12, 2012.

SECOND QUARTER 2012 SEGMENT RESULTS

Below is a summary of business segment results:

($ in millions)

   Derivatives      Cash Trading & Listings      Info. Svcs. & Tech. Solutions  
   Net
Revenue1
     Operating
Income2
     Adjusted
EBITDA2
     Net
Revenue1
     Operating
Income2
     Adjusted
EBITDA2
     Revenue      Operating
Income2
     Adjusted
EBITDA2
 

2Q12

     $182         $85         $95         $300         $127         $170         $119         $27         $40   

1Q12

     $176         $79         $89         $304         $119         $161         $121         $28         $42   

2Q11

     $213         $112         $126         $327         $128         $174         $122         $36         $46   

YTD 2012

     $358         $164         $184         $604         $246         $331         $240         $55         $82   

YTD 2011

     $449         $258         $287         $655         $253         $345         $238         $64         $83   

 

1

Net revenue defined as total revenues less transaction-based expenses including Section 31 fees, liquidity payments and routing & clearing fees.

2 

Excludes merger expenses and exit costs.

DERIVATIVES

Derivatives net revenue of $182 million in the second quarter of 2012 decreased $31 million, or 15% compared to the second quarter of 2011 and included a $6 million negative impact from foreign currency fluctuations. The $25 million decrease in derivatives net revenue, on a constant currency basis, compared to the second quarter of 2011, was driven by lower trading volumes.

 

 

Global derivatives ADV in the second quarter of 2012 of 8.6 million contracts decreased 8% compared to the second quarter of 2011, but increased 14% compared to first quarter of 2012 levels.

 

 

NYSE Euronext European derivatives products ADV of 4.7 million contracts in the second quarter of 2012 decreased 12% compared to the second quarter of 2011, but increased 40% from first quarter of 2012 levels. Excluding Bclear, European derivatives products ADV in the second quarter of 2012 decreased 8% compared to the second quarter of 2011, but increased 9% from the first quarter of 2012.

 

3


 

On June 29, 2012, NYSE Euronext gave formal notice of termination with respect to the services currently received from LCH.Clearnet Ltd under the Clearing Relationship Agreement to support NYSE Liffe Clearing, NYX’s London-based derivatives clearing service. Subject to regulatory approval, NYSE Liffe intends to expand NYSE Liffe Clearing to commence functioning as a fully integrated Central Counterparty, NYSE Clearing, from the end of June 2013. NYSE Clearing will assume responsibility for default management arrangements, risk management, collateral and treasury activities as well as banking and payment systems.

 

 

U.S. equity options ADV in the second quarter of 2012 decreased 3% to 3.9 million contracts compared to the second quarter of 2011 and decreased 5% from the first quarter of 2012. U.S. consolidated equity options ADV of 14.9 million contracts decreased 5% compared to the second quarter of 2011 and decreased 6% from the first quarter of 2012. NYSE Euronext’s U.S. equity options exchanges accounted for 26.3% of total consolidated U.S. equity options trading in the second quarter of 2012, up from 25.7% in the second quarter of 2011 and up from 26.0% in the first quarter of 2012. NYSE Amex Options had record quarterly market share in the second quarter of 2012 of 15.7%.

 

 

NYSE Liffe U.S. ADV in the second quarter of 2012 was approximately 73,400 contracts compared to 93,400 contracts in the second quarter of 2011 and 96,300 contracts in the first quarter of 2012. At the end of the second quarter 2012, NYSE Liffe U.S. celebrated the one-year anniversary as the sole U.S. futures exchange trading contracts based on MSCI indices. The indices have registered strong growth in volume and open interest over the past year, particularly in the contracts based on the benchmark MSCI Emerging Markets and MSCI EAFE indices. Nearly 190,000 lots of mini MSCI Index futures open interest are currently established on NYSE Liffe U.S., representing a notional value of over $10 billion. Open interest in the mini MSCI Emerging Markets contracts and mini MSCI EAFE contracts have increased 204% to 117,529 and 108% to 67,828, respectively since the migration from the CME in June 2011.

 

 

NYSE Liffe U.S. continued to expand the product breadth of the platform with the launch of futures on the DTCC GCF Repo Index. Additionally, in June 2012 NYSE Liffe U.S. sold a 7% equity stake in the business to the existing partner group, raising the partner groups’ collective stake in the business to 49%.

CASH TRADING AND LISTINGS

Cash Trading and Listings net revenue of $300 million in the second quarter of 2012 decreased $27 million, or 8% compared to the second quarter of 2011 and included an $11 million negative impact from foreign currency fluctuations. The $16 million decrease in net revenue, on a constant currency basis, compared to the second quarter of 2011 was primarily driven by lower average net revenue capture for European cash trading.

 

 

European cash ADV of 1.7 million transactions in the second quarter of 2012 increased 11% from 1.5 million transactions in the second quarter of 2011 and increased 8% from first quarter of 2012 levels. European cash market share (value traded) in NYSE Euronext’s four core markets was 66% in the second quarter of 2012, down from 71% in the second quarter of 2011, but up from 65% in the first quarter of 2012.

 

 

In the U.S., cash trading ADV in the second quarter of 2012 decreased 12% to 1.8 billion shares traded from 2.1 billion in the second quarter of 2011, but increased 2% from the first quarter of 2012. Tape A matched market share was 32% in the second quarter of 2012, down from 35% in the second quarter of 2011, but up from 31% in the first quarter of 2012.

 

 

NYSE Euronext received approval from the U.S. Securities and Exchange Commission to establish a first-of-its-kind Retail Liquidity Program (“RLP”), a market innovation that produces cost savings for individual investors through price improvement on retail equities trading order flow for New York Stock

 

4


 

Exchange (NYSE) and NYSE MKT listed and NASDAQ UTP-traded equity securities. The RLP is complementary to existing marketplace offerings for retail investors and is intended for use by retail brokerage firms directly and market intermediaries that service retail order flow providers.

 

 

In the first half of 2012, NYSE Euronext raised $17.1 billion in total global proceeds on 66 Initial Public Offerings (IPOs). In the U.S., NYSE Euronext listed 62% of all IPOs, bringing 56 IPOs to the U.S. market. NYSE Euronext has steadily captured share in technology-based IPOs. In the first half of 2012, NYSE Euronext listed 52% of the technology IPOs in the U.S., including the recent IPO of ServiceNow, Inc. Technology-based listings on NYSE in the first half of 2012 included Demandware Inc., Exact Target Inc., Guidewire Software Inc., Infoblox Inc., Millennial Media Inc. and Yelp Inc. For the second half of 2012, the pipeline of technology deals is strong.

 

 

In the first half of 2012, eight companies transferred to the NYSE with three departures from the NYSE and one from NYSE MKT. Of the eight companies that moved to the NYSE in 2012, two were among the top 100 market capitalization companies listed on NASDAQ - Teva Pharmaceutical Industries Ltd., which was part of the NASDAQ 100 Index and TD Ameritrade Holding Corporation. Since 2010, a total of 38 companies have transferred to NYSE and 14 have transferred to another U.S. exchange giving NYSE Euronext a win rate of approximately 3:1.

 

 

In Europe, Groupe Eurotunnel was the first company to be admitted to NYSE Euronext London and began trading on July 19, 2012. BTG Pactual, Brazil’s largest investment bank, listed on NYSE Alternext Amsterdam and Solvay, a leading global player in chemicals completed a secondary listing on NYSE Euronext in Paris. In the U.S., global industry leaders such as AVG Technologies NV from Czech Republic, Cementos Pacasmayo from Peru and Cencosud S.A. from Chile, all listed on NYSE.

 

 

NYSE Euronext acquired Corpedia Corporation, a leading global provider of ethics and compliance e-learning and consultative services. With its corporate governance, risk and compliance (GRC) assets, Corpedia will further expand NYSE Euronext’s extensive range of global services available to companies. The transaction closed in June 2012.

INFORMATION SERVICES AND TECHNOLOGY SOLUTIONS

Information Services and Technology Solutions revenue was $119 million in the second quarter of 2012, a decrease of $3 million, or 2% compared to the second quarter of 2011 and included a $5 million negative impact from foreign currency fluctuations. The $2 million increase in revenue, on a constant currency basis, compared to the second quarter of 2011, was driven by higher connectivity revenue. The slower growth in revenue year-over-year is the result of the challenging environment for financial services technology sales which has delayed client decisions on purchases of software and connectivity services.

 

 

NYSE Technologies announced a market data partnership with the Warsaw Stock Exchange (WSE). Customers will now have access to the WSE’s market data services via NYSE Technologies’ innovative suite of market data products and services. NYSE Euronext and the WSE continue their strategic collaboration (initially formed in 2010) working on a series of projects including the ongoing implementation of the NYSE Technologies Universal Trading Platform and the continuing development of a range of technology cooperation for the WSE.

 

 

NYSE Technologies announced the global expansion of its successful Capital Markets Community Platform into Europe. Operating from NYSE Euronext’s European liquidity center in Basildon, the cloud based Community Platform was designed and developed in partnership with leading computing experts EMC and VMware. NYSE Technologies’ Capital Markets Community Platform was designed to increase business agility, simplify market access and reduce trading friction by utilizing rapid on-demand computing resources. Originally launched on July 1, 2011 from NYSE Euronext’s U.S. liquidity center in Mahwah, this is the first cloud based capital markets community platform developed exclusively for the financial services industry.

 

5


 

NYSE Euronext announced that its U.S. liquidity center in Mahwah, New Jersey has enhanced its data center community, managed by NYSE Technologies, by revising a number of policies aimed at reducing customer costs, increasing platform flexibility and broadening access to the facility. For the first time, the financial services vendor community has the opportunity to acquire data center space and offer their services within NYSE Technologies’ state-of-the-art liquidity center.

 

 

NYSE Technologies and Xignite Inc., a provider of web-based market data services, announced their agreement to launch a new service providing access to real-time, historical and reference market data for all NYSE Euronext markets via the Internet.

# # #

The accompanying tables include information integral to assessing the Company’s financial performance.

Analyst/Investor/Media Call: August 3, 2012 at 8:00 a.m. (NY/ET) / 2:00 p.m. (Paris/CEST)

A presentation and live audio webcast of the Second quarter 2012 earnings conference call will be available on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir. Those wishing to listen to the live conference via telephone should dial-in at least ten minutes before the call begins. An audio replay of the conference call will be available approximately one hour after the call on the Investor Relations section of NYSE Euronext’s website, http://www.nyseeuronext.com/ir or by dial-in beginning approximately two hours following the conclusion of the live call.

Live Dial-in Information:

United States: 800.901.5241

International: 617.786.2963

Passcode: 71048755

Replay Dial-in Information:

United States: 888.286.8010

International: 617.801.6888

Passcode: 97290929

Non-GAAP Financial Measures

To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that either exclude or include amounts that are not normally excluded or included in the most directly comparable measure, calculated and presented in accordance with GAAP. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results, but are provided to (i) present the effects of certain merger expenses, exit costs, the BlueNext tax settlement, disposal activities and discrete tax items, and (ii) improve overall understanding of NYSE Euronext’s current financial performance and its prospects for the future. Specifically, NYSE Euronext believes the non-GAAP financial results provide useful information to both management and investors regarding certain additional financial and business trends relating to financial condition and operating results. In addition, management uses these measures for reviewing financial results and evaluating financial performance. The non-GAAP adjustments for all periods presented are based upon information and assumptions available as of the date of this release.

LOGO NYSE Euronext Earnings News Release with Tables and Operating Data

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company’s exchanges in Europe and the United States trade equities, futures, options, fixed-

 

6


income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext’s equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world’s second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

 

7


NYSE Euronext

Condensed consolidated statements of income (unaudited)

(in millions, except per share data)

 

     Three months ended,           Six months ended June 30,  
     June 30, 2012      March 31, 2012      June 30, 2011           2012      2011  

Revenues

                     

Transaction and clearing fees

     $ 649           $ 609           $ 742              $ 1,258           $ 1,557     

Market data

     87           91           92              178           188     

Listing

     112           110           112              222           221     

Technology services

     87           86           89              173           171     

Other revenues

     51           56           57              107           103     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Total revenues

     986           952           1,092              1,938           2,240     

Transaction-based expenses:

                     

Section 31 fees

     86           66           89              152           178     

Liquidity payments, routing and clearing

     298           285           342              583           722     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Total revenues, less transaction-based expenses

     602           601           661              1,203           1,340     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Other operating expenses

                     

Compensation

     152           160           158              312           319     

Depreciation and amortization

     66           66           70              132           140     

Systems and communications

     44           45           45              89           97     

Professional services

     69           73           73              142           142     

Selling, general and administrative

     65           61           73              126           136     

Merger expenses and exit costs

     12           31           18              43           39     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Total other operating expenses

     408           436           437              844           873     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Operating income

     194           165           224              359           467     

Net interest and investment income (loss)

     (28)          (28)          (30)             (56)          (59)    

Loss from associates

     (2)          (1)          (2)             (3)          (3)    

Net loss on disposal activities

     (2)          -             -                (2)          -       

Other income

     3           -             1              3           1     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Income before income taxes

     165           136           193              301           406     

Income tax provision

     (34)          (45)          (43)             (79)          (105)    
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Net income

     131           91           150              222           301     

Net (income) loss attributable to noncontrolling interest

     (6)          (4)          4              (10)          8     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Net income attributable to NYSE Euronext

     $ 125           $ 87         $ 154              $ 212           $ 309     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Basic earnings per share attributable to NYSE Euronext

     $ 0.50           $ 0.34           $ 0.59              $ 0.83           $ 1.18     

Diluted earnings per share attributable to NYSE Euronext

     $ 0.49           $ 0.34           $ 0.59            $ 0.83           $ 1.17     

Basic weighted average shares outstanding

     252           258           262              255           262     

Diluted weighted average shares outstanding

     253           259           263              256           263     

We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

     Three months ended,           Six months ended June 30,  
Non-GAAP Reconciliation    June 30, 2012      March 31, 2012      June 30, 2011           2012      2011  

Income (loss) before income taxes - GAAP

     $ 165           $ 136           $ 193              $ 301           $ 406     

Excluding:

                 

Merger expenses and exit costs

     12           31           18              43           39     

Net loss on disposal activities

     2           -             -                2           -       
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Income before income taxes - as adjusted

     179           167           211              346           445     

Income tax provision

     (45)          (42)          (55)             (87)          (116)    
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Net income - as adjusted

     134           125           156              259           329     

Net (income) loss attributable to noncontrolling interest

     (6)          (4)          4              (10)          8     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Net income attributable to NYSE Euronext - as adjusted

     $ 128           $ 121           $ 160              $ 249           $ 337     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Diluted earnings per share attributable to NYSE Euronext

     $ 0.51           $ 0.47           $ 0.61              $ 0.97           $ 1.28     
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

8


NYSE Euronext

Segment Results (unaudited)

(in millions)

 

     Three months ended
June 30, 2012
         Three months ended
June 30, 2011
 
     Derivatives     Cash Trading
and Listings
    Information
Services and
Technology
Solutions
    Corporate
and
Eliminations
     Consolidated          Derivatives     Cash
Trading and
Listings
    Information
Services and
Technology
Solutions
    Corporate and
Eliminations
     Consolidated  

Revenues

                               

Transaction and clearing fees

       $ 219          $ 430          $ -            $ -             $ 649             $ 251          $ 491          $ -            $ -             $ 742     

Market data

       11          44          32          -             87             12          48          32          -             92   

Listing

       -            112          -            -             112             -            112          -            -             112     

Technology services

       -            -            87          -             87             -            -            90          (1)          89     

Other revenues

       10          40          -            1           51             13          44          -            -             57     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total revenues

       240          626          119          1           986             276          695          122          (1)          1,092     

Transaction-based expenses:

                               

Section 31 fees

       -            86          -            -             86             -            89          -            -             89     

Liquidity payments, routing and clearing

       58          240          -            -               298             63          279          -            -             342     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total revenues, less transaction-based expenses

       182          300          119          1           602             213          327          122          (1)          661     

Depreciation and amortization

  [a]      10          43          13          -             66             14          46          10          -             70     

Merger expenses and exit costs (M&E)

  [b]      7          7          4          (6)          12             1          2          1          14           18     

Other operating expenses

       87          130          79          34           330             87          153          76          33           349     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Operating income - GAAP

  [c]      $ 78          $ 120          $ 23          $ (27)          $ 194             $ 111          $ 126          $ 35          $ (48)          $ 224     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Operating income excluding M&E

  [c] + [b]      $ 85          $ 127          $ 27          $ (33)          $ 206             $ 112          $ 128          $ 36          $ (34)          $ 242     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Adjusted EBITDA

  [c] + [a] + [b]      $ 95          $ 170          $ 40          $ (33)          $ 272             $ 126          $ 174          $ 46          $ (34)          $ 312     

Operating margin excluding M&E

       47     42     23     N/M         34        53     39     30     N/M         37

Adjusted EBITDA margin

       52     57     34     N/M         45        59     53     38     N/M         47

 

         Six months ended
June 30, 2012
         Six months ended
June 30, 2011
 
     Derivatives     Cash Trading
and Listings
    Information
Services and
Technology
Solutions
    Corporate
and
Eliminations
     Consolidated          Derivatives     Cash
Trading  and
Listings
    Information
Services and
Technology
Solutions
    Corporate and
Eliminations
     Consolidated  

Revenues

                               

Transaction and clearing fees

       $ 425          $ 833          $ -            $ -             $ 1,258             $ 537          $ 1,020          $ -            $ -             $ 1,557     

Market data

       22          89          67          -             178             24          98          66          -             188     

Listing

       -            222          -            -             222             -            221          -            -             221     

Technology services

       -            -            173          -             173             -            -            172          (1)          171     

Other revenues

       22          84          -            1           107             22          82          -            (1)          103     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total revenues

       469          1,228          240          1           1,938             583          1,421          238          (2)          2,240     

Transaction-based expenses:

                               

Section 31 fees

       -            152          -            -             152             -            178          -                -             178     

Liquidity payments, routing and clearing

       111          472          -            -             583             134          588          -            -             722     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total revenues, less transaction-based expenses

       358          604          240          1           1,203             449          655          238          (2)          1,340     

Depreciation and amortization

  [a]      20          85          27          -             132             29          92          19          -             140     

Merger expenses and exit costs (M&E)

  [b]      8          13          10          12           43             2          5          2          30           39     

Other operating expenses

       174          273          158          64           669             162          310          155          67           694     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Operating income-GAAP

  [c]      $ 156          $ 233          $ 45        $ (75)          $ 359             $ 256          $ 248          $ 62          $ (99)          $ 467     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Operating income excluding M&E

  [c] + [b]      $ 164          $ 246          $ 55          $ (63)          $ 402             $ 258          $ 253          $ 64          $ (69)          $ 506     
    

 

 

   

 

 

   

 

 

   

 

 

    

 

 

      

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Adjusted EBITDA

  [c] + [a] + [b]      $ 184          $ 331          $ 82          $ (63)          $ 534             $ 287          $ 345          $ 83          $ (69)          $ 646     

Operating margin excluding M&E

       46 %        41 %        23 %        N/M           33 %           57     39     27     N/M         38

Adjusted EBITDA margin

       51 %        55 %        34 %        N/M           44 %           64     53     35     N/M         48

 

N/M = Not meaningful    We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of N/M = Not meaningful our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

 

9


NYSE Euronext

Fixed operating expenses (unaudited)

(in millions)

 

Fixed operating expenses for the three months ended June 30, 2012 - GAAP

    $              408            

Less:

         

Merger expenses and exit costs

     (12)          
  

 

 

        
    $ 396            

Excluding the impact of:

         

Currency translation

     11            

New business initiatives

     (11)           
  

 

 

      

Fixed operating expenses for the three months ended June 30, 2012 - as adjusted

    $ (396)            [a]
  

 

 

      
   

Fixed operating expenses for the three months ended June 30, 2011 - GAAP

    $ 437            

Less:

         

Merger expenses and exit costs

     (18)           
  

 

 

        
    $ 419             [b]
  

 

 

        

Variance ($)

    $ (23)            [a] -[b] = [c]
  

 

 

        

Variance (%)

     -5%                 [c] / [b]

    

       

Fixed operating expenses for the six months ended June 30, 2012 - GAAP

    $ 844            

Less:

         

Merger expenses and exit costs

     (43)           
  

 

 

        
    $ 801            

Excluding the impact of:

         

Currency translation

     16            

New business initiatives

     (18)           
  

 

 

        

Fixed operating expenses for the six months ended June 30, 2012 - as adjusted

    $ 799             [a]
   

Fixed operating expenses for the six months ended June 30, 2011 - GAAP

    $ 873            

Less:

         

Merger expenses and exit costs

     (39)           
  

 

 

        
    $ 834             [b]
  

 

 

        

Variance ($)

    $ (35)            [a] -[b] = [c]
  

 

 

        

Variance (%)

     -4%            [c] / [b]

  We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results but are provided to improve overall understanding of our current financial performance and our prospects for the future.

 

10


NYSE Euronext

Condensed consolidated statements of financial condition (unaudited)

(in millions)

 

         June 30,    
2012
     December 31,
2011
 

Assets

     

Current assets:

     

Cash, cash equivalents, and short term financial investments

     $ 416           $ 432     

Accounts receivable, net

     495           497     

Deferred income taxes

     68           108     

Other current assets

     172           152     
  

 

 

    

 

 

 

Total current assets

     1,151           1,189     

Property and equipment, net

     943           963     

Goodwill

     4,082           4,027     

Other intangible assets, net

     5,617           5,697     

Deferred income taxes

     548           594     

Other assets

     636           637     
  

 

 

    

 

 

 

Total assets

     $ 12,977           $ 13,107     
  

 

 

    

 

 

 

Liabilities and equity

     

Accounts payable and accrued expenses

     $ 877           $ 992     

Deferred revenue

     313           130     

Short term debt

     270           39     

Deferred income taxes

     21           23     
  

 

 

    

 

 

 

Total current liabilities

     1,481           1,184     

Long term debt

     2,007           2,036     

Deferred income taxes

     1,885           1,900     

Accrued employee benefits

     565           620     

Deferred revenue

     369           371     

Other liabilities

     24           63     
  

 

 

    

 

 

 

Total liabilities

     6,331           6,174     
  

 

 

    

 

 

 

Redeemable noncontrolling interest

     294           295     
  

 

 

    

 

 

 

Equity

     6,352           6,638     
  

 

 

    

 

 

 

Total liabilities and equity

     $       12,977           $       13,107     
  

 

 

    

 

 

 

 

11


    

NYSE Euronext

Selected Statistical Data:

Volume Summary

                                     
     Average Daily Volume     Total Volume     Total Volume  
(Unaudited)    2Q12     1Q12     r 2Q12
vs. 1Q12
    2Q11     r 2Q12
vs. 2Q11
    2Q12     1Q12     r 2Q12
vs. 1Q12
    2Q11     r 2Q12
vs. 2Q11
    YTD 2012     YTD 2011     % r  

Number of Trading Days - European Cash

     62        65          63          62        65          63          127        127     

Number of Trading Days - European Derivatives

     63        65          63          63        65          63          128        127     

Number of Trading Days - U.S. Markets

     63        62          63          63        62          63          125        125     
                          

European Derivatives Products (contracts in thousands)

     4,654        3,332        39.7     5,294        -12.1     293,182        216,595        35.4     333,522        -12.1     509,777        630,051        -19.1

of which Bclear

     1,743        673        159.1     2,125        -18.0     109,827        43,730        151.1     133,874        -18.0     153,556        183,210        -16.2

Avg. Net Revenue Per Contract (ex. Bclear)

   $ 0.671      $ 0.659        1.8   $ 0.741        -9.4   $ 0.671      $ 0.659        1.8   $ 0.741        -9.4      

Avg. Net Revenue Per Contract (ex. Bclear)-Currency Neutral

   $ 0.671      $ 0.664        1.1   $ 0.719        -6.7   $ 0.671      $ 0.664        1.1   $ 0.719        -6.7      
                          

Total Interest Rate Products1

     1,953        1,774        10.1     2,147        -9.0     123,059        115,327        6.7     135,231        -9.0     238,387        308,023        -22.6
                          

Short Term Interest Rate Products

     1,801        1,622        11.0     2,006        -10.2     113,479        105,438        7.6     126,347        -10.2     218,917        290,718        -24.7

Medium and Long Term Interest Rate Products

     152        152        -0.1     141        7.8     9,580        9,889        -3.1     8,884        7.8     19,469        17,305        12.5
                          

Total Equity Products2

     2,622        1,477        77.6     3,063        -14.4     165,188        95,974        72.1     192,980        -14.4     261,162        311,090        -16.0
                          

Individual Equity Products

     2,065        1,019        102.6     2,535        -18.5     130,086        66,242        96.4     159,703        -18.5     196,328        240,714        -18.4

Futures

     1,603        510        214.0     1,984        -19.2     100,962        33,175        204.3     124,971        -19.2     134,137        161,748        -17.1

Options

     462        509        -9.1     551        -16.1     29,124        33,068        -11.9     34,731        -16.1     62,191        78,965        -21.2

Equity Index Products

     557        457        21.8     528        5.5     35,102        29,732        18.1     33,277        5.5     64,834        70,377        -7.9

of which Bclear

     1,743        673        159.1     2,125        -18.0     109,827        43,730        151.1     133,874        -18.0     153,556        183,210        -16.2

Individual Equity Products

     1,667        600        177.9     2,053        -18.8     105,025        38,998        169.3     129,324        -18.8     144,023        173,476        -17.0

Futures

     1,561        502        210.6     1,959        -20.3     98,312        32,660        201.0     123,429        -20.3     130,972        159,866        -18.1

Options

     107        98        9.3     94        13.9     6,713        6,339        5.9     5,895        13.9     13,051        13,610        -4.1

Equity Index Products

     76        73        4.7     72        5.5     4,801        4,731        1.5     4,551        5.5     9,533        9,734        -2.1
                          

Commodity Products

     78        81        -3.8     84        -7.1     4,935        5,293        -6.8     5,312        -7.1     10,228        10,938        -6.5
                          

U.S. Derivatives Products (contracts in thousands)

  

               

Avg. Net Revenue Per Contract (ex. Liffe U.S. volumes)

   $ 0.150      $ 0.148        1.4   $ 0.165        -9.1   $ 0.150      $ 0.148        1.4   $ 0.165        -9.1      
                          

Equity Options Contracts3

     3,915        4,128        -5.2     4,052        -3.4     246,634        255,922        -3.6     255,306        -3.4     502556        528738.2        -5.0

Total Consolidated Options Contracts

     14,911        15,879        -6.1     15,759        -5.4     939,423        984,508        -4.6     992,810        -5.4     1,923,930        2,065,771        4.4

Share of Total Consolidated Options Contracts

     26.3     26.0       25.7       26.3     26.0       25.7       26.1     25.6     0.5
                          

NYSE Liffe U.S.

  

                 
                          

Futures and Futures Options Volume

     73.4        96.3        -23.8     93.4        -21.5     4,769.3        6,161.3        -22.6     5,980.7        -20.3     10,930.6        7,325.2        49.2
                          

European Cash Products (trades in thousands)

     1,709        1,583        7.9     1,540        11.0     105,934        102,927        2.9     96,999        9.2     208,861        212,376        -1.7
                          

Avg. Net Revenue Per Transaction

   $ 0.519      $ 0.573        -9.4   $ 0.742        -30.1   $ 0.519      $ 0.573        -9.4   $ 0.742        -30.1      

Avg. Net Revenue Per Transaction - Currency Neutral

   $ 0.519      $ 0.561        -7.5   $ 0.662        -21.6   $ 0.519      $ 0.561        -7.5   $ 0.662        -21.6      

Equities

     1,656        1,530        8.2     1,482        11.8     102,668        99,439        3.2     93,350        10.0     202,107        204,191        -1.0

Exchange-Traded Funds

     14        14        -1.0     16        -12.4     890        942        -5.5     1,032        -13.8     1,831        2,348        -22.0

Structured Products

     33        34        -3.4     36        -8.9     2,059        2,235        -7.9     2,298        -10.4     4,294        5,171        -16.9

Bonds

     5        5        6.9     5        0.8     317        311        2.0     319        -0.8     628        667        -5.9
                          

U.S. Cash Products (shares in millions)

     1,818        1,783        2.0     2,075        -12.4     114,541        110,557        3.6     130,722        -12.4     225,100        273,905        -17.8

Avg. Net Revenue Per 100 Shares Handled

   $ 0.0428      $ 0.0425        0.7   $ 0.0390        9.7   $ 0.0428      $ 0.0425        0.7   $ 0.0390        9.7      
                          

NYSE Listed (Tape A) Issues 4

  

               

Handled Volume 5

     1,300        1,275        2.0     1,461        -11.0     81,899        79,023        3.6     92,072        -11.0     160,922        195,469        -17.7

Matched Volume 6

     1,235        1,202        2.8     1,384        -10.8     77,823        74,532        4.4     87,216        -10.8     152,355        185,021        -17.7

Total NYSE Listed Consolidated Volume

     3,881        3,932        -1.3     3,935        -1.4     244,497        243,800        0.3     247,909        -1.4     488,298        531,121        -8.1
                          

Share of Total Consolidated Volume

  

                 

Handled Volume 5

     33.5     32.4     1.1     37.1     -3.6     33.5     32.4     1.1     37.1     -3.6     33.0     36.8     -3.8

Matched Volume 6

     31.8     30.6     1.2     35.2     -3.4     31.8     30.6     1.2     35.2     -3.4     31.2     34.8     -3.6
                          

NYSE Arca, MKT and Regional (Tape B) Listed Issues

  

               
                          

Handled Volume 5

     278        265        4.9     335        -16.9     17,519        16,441        6.6     21,085        -16.9     33,960        42,575        -20.2

Matched Volume 6

     250        237        5.7     301        -16.9     15,763        14,670        7.4     18,976        -16.9     30,433        38,246        -20.4

Total NYSE Arca & NYSE MKT Listed Consolidated Volume

     1,187        1,123        5.7     1,287        -7.8     74,780        69,623        7.4     81,111        -7.8     144,402        164,862        -12.4
                          

Share of Total NYSE Arca & NYSE MKT Listed Consolidated Volume

  

           

Handled Volume 5

     23.4     23.6     85.3     26.0     -2.6     23.4     23.6     -0.2     26.0     -2.6     23.5     25.8     -2.3

Matched Volume 6

     21.1     21.1     100.7     23.4     -2.3     21.1     21.1     0.0     23.4     -2.3     21.1     23.2     -2.1
                          

Nasdaq Listed Issues (Tape C)

  

               
                          

Handled Volume 5

     240        243        -1.4     279        -14.1     15,123        15,095        0.2     17,597        -14.1     30,218        35,892        -15.8

Matched Volume 6

     206        206        -0.3     237        -13.2     12,950        12,776        1.4     14,924        -13.2     25,726        30,495        -15.6

Total Nasdaq Listed Consolidated Volume

     1,802        1,796        0.4     1,996        -9.7     113,554        111,330        2.0     125,745        -9.7     224,885        252,911        -11.1
                          

Share of Total Nasdaq Listed Consolidated Volume

  

             

Handled Volume 5

     13.3     13.6     -0.3     14.0     -0.7     13.3     13.6     -0.3     14.0     -0.7     13.4     14.2     -0.8

Matched Volume 6

     11.4     11.5     -0.1     11.9     -0.5     11.4     11.5     -0.1     11.9     -0.5     11.4     12.1     -0.7
                          

Exchange-Traded Funds 5,7

  

                 
                          

Handled Volume 5

     265        248        6.6     309        -14.2     16,693        15,407        8.3     19,446        -14.2     32,100        39,003        -17.7

Matched Volume 6

     238        221        7.6     277        -14.2     14,995        13,718        9.3     17,468        -14.2     28,714        35,010        -18.0

Total ETF Consolidated Volume

     1,167        1,084        7.6     1,210        -3.6     73,495        67,197        9.4     76,252        -3.6     140,693        153,464        -8.3
                          

Share of Total ETF Consolidated Volume

  

             

Handled Volume 5

     22.7     22.9     -0.2     25.5     -2.8     22.7     22.9     -0.2     25.5     -2.8     22.8     25.4     -2.6

Matched Volume 6

     20.4     20.4     0.0     22.9     -2.5     20.4     20.4     0.0     22.9     -2.5     20.4     22.8     -2.4

 

 

1 

Data includes currency products.

2

Includes trading activities for Bclear, NYSE Liffe’s service for Equity OTC derivatives.

3 

Includes trading in U.S. equity options contracts, not equity-index options.

4 

Includes all volume executed in NYSE Euronext’s U.S. crossing sessions.

5 

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Euronext’s U.S. exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

6 

Represents the total number of shares of equity securities and ETFs executed on the NYSE Euronext’s U.S. exchanges.

7 

Data included in previously identified categories.

* 

ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

 

12


NYSE Euronext

Selected Statistical Data:

Other Operating Statistics

 

     Three Months Ended  
(Unaudited)          June 30, 2012                  Mar. 31, 2012                  June 30, 2011        
        

NYSE Euronext Listed Issuers

        
        

NYSE Listed Issuers

        
        

Issuers listed on U.S. Markets1

     2,968         2,960         2,956   

Number of new issuer listings1

     75         106         155   

Capital raised in connection with new listings ($millions)2

     $5,086         $4,492         $11,709   
        

Euronext Listed Issuers

        
        

Issuers listed on Euronext1

     923         926         964   

Number of new issuer listings3

     10         10         20   

Capital raised in connection with new listings ($millions)2

     $1,912         $1,461         $72   
        
        

NYSE Euronext Market Data

        
        

NYSE Market Data4

        
        

Share of Tape A revenues (%)

     41.4%         40.2%         45.8%   

Share of Tape B revenues (%)

     27.0%         27.0%         30.2%   

Share of Tape C revenues (%)

     15.1%         15.6%         18.4%   

Professional subscribers (Tape A)

     360,121         362,617         383,606   
        

Euronext Market Data

        
        

Number of terminals

     216,752         221,906         231,544   
        

NYSE Euronext Operating Expenses

        
        

NYSE Euronext employee headcount

        
        

NYSE Euronext headcount5

     3,062         3,079         2,988   
        

NYSE Euronext Financial Statistics

        
        

NYSE Euronext foreign exchange rate

        
        

Average €/US$exchange rate

     $1.254         $1.311         $1.439   

Average £/US$exchange rate

     $1.583         $1.571         $1.631   

 

1 Figures for NYSE listed issuers include listed operating companies, special-purpose acquisition companies and closed-end funds listed on the NYSE and NYSE MKT and do not include NYSE Arca or structured products listed on the NYSE. There were 1,407 ETPs exclusively listed on NYSE Arca as of June 30, 2012. There were 439 corporate structured products listed on the NYSE as of June 30, 2012.

Figures for new issuer listings include NYSE new listings (including new operating companies, special-purpose acquisition companies and closed-end funds listing on NYSE) and new ETP listings on NYSE Arca (NYSE MKT is excluded). Figures for Euronext present the operating companies were listed on Euronext and do not include NYSE Alternext, Free Market, closed-end funds, ETFs and structured product (warrants and certificates). As of June 30, 2012, 182 companies were listed on NYSE Alternext, 264 on Free Market and 686 ETPs were listed on NextTrack.

 

2 Euronext figures show capital raised in millions of dollars by operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates). NYSE figures show capital raised in millions of dollars by operating companies listed on NYSE and NYSE Arca and do not include closed-end funds, ETFs and structured products.

 

3 Euronext figures include operating companies listed on Euronext, NYSE Alternext and Free Market and do not include closed-end funds, ETFs and structured products (warrants and certificates).

 

4 “Tape A” represents NYSE listed securities, “Tape B” represents NYSE Arca and NYSE MKT listed securities, and “Tape C” represents Nasdaq listed securities. Per Regulation NMS, as of April 1, 2007, share of revenues is derived through a formula based on 25% share of trading, 25% share of value traded, and 50% share of quoting, as reported to the consolidated tape. Prior to April 1, 2007, share of revenues for Tape A and B was derived based on number of trades reported to the consolidated tape, and share of revenue for Tape C was derived based on an average of share of trades and share of volume reported to the consolidated tape. The consolidated tape refers to the collection and dissemination of market data that multiple markets make available on a consolidated basis. Share figures exclude transactions reported to the FINRA/NYSE Trade Reporting Facility.

 

5 Headcount for June 30, 2012 includes 99 employees in connection with the recent acquisitions of Corpedia.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

 

13